[{"notes_id":"1_379","category":"9","subcategory":"2","title":"Parkinson's disease: management","body":"Parkinsons disease should only be diagnosed, and management initiated, by a <span class=\"concept\" data-cid=\"5645\">specialist<\/span> with expertise in movement disorders. However, it is important for all doctors to be aware of the medications used in Parkinson's given the prevalence of this condition. NICE published guidelines in 2017 regarding the management of Parkinson's disease.<br \/><br \/>For first-line treatment:<br \/><ul><li>if the motor symptoms are affecting the patient's quality of life: <span class=\"concept\" data-cid=\"1213\">levodopa<\/span><\/li><li>if the motor symptoms are not affecting the patient's quality of life: dopamine agonist (non-ergot derived), levodopa or monoamine oxidase B (MAO-B) inhibitor<\/li><\/ul><br \/>Whilst all drugs used to treat Parkinson's can cause a wide variety of side-effects NICE produced tables to help with decision making:<br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><\/th><th>Levodopa<\/th><th>Dopamine agonists<\/th><th>MAO-B inhibitors<\/th><\/tr><\/thead><tbody><tr><td><b>Motor symptoms<\/b><\/td><td><span class=\"concept\" data-cid=\"1214\">More improvement in motor symptoms<\/span><\/td><td>Less improvement in motor symptoms<\/td><td>Less improvement in motor symptoms<\/td><\/tr><tr><td><b>Activities of daily living<\/b><\/td><td><span class=\"concept\" data-cid=\"1214\">More improvement in activities of daily living<\/span><\/td><td>Less improvement in activities of daily living<\/td><td>Less improvement in activities of daily living<\/td><\/tr><tr><td><b>Motor complications<\/b><\/td><td>More motor complications<\/td><td>Fewer motor complications<\/td><td>Fewer motor complications<\/td><\/tr><tr><td><b>Adverse events<\/b><\/td><td>Fewer specified adverse events*<\/td><td>More specified adverse events*<\/td><td>Fewer specified adverse events*<\/td><\/tr><\/tbody><\/table><\/div>* excessive sleepiness, <span class=\"concept\" data-cid=\"4334\">hallucinations<\/span> and impulse control disorders<br \/><br \/>If a patient continues to have symptoms despite optimal levodopa treatment or has developed dyskinesia then NICE recommend the addition of a dopamine agonist, MAO-B inhibitor or catechol-O-methyl transferase (COMT) inhibitor as an adjunct. Again, NICE summarise the main points in terms of decision making:<br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><\/th><th>Dopamine agonists<\/th><th>MAO-B inhibitors<\/th><th>COMT inhibitors<\/th><th>Amantadine<\/th><\/tr><\/thead><tbody><tr><td><b>Motor symptoms<\/b><\/td><td>Improvement in motor symptoms<\/td><td>Improvement in motor symptoms<\/td><td>Improvement in motor symptoms<\/td><td>No evidence of improvement in motor symptoms<\/td><\/tr><tr><td><b>Activities of daily living<\/b><\/td><td>Improvement in activities of daily living<\/td><td>Improvement in activities of daily living<\/td><td>Improvement in activities of daily living<\/td><td>No evidence of improvement in activities of daily living<\/td><\/tr><tr><td><b>Off time<\/b><\/td><td>More off-time reduction<\/td><td>Off-time reduction<\/td><td>Off-time reduction<\/td><td>No studies reporting this outcome<\/td><\/tr><tr><td><b>Adverse events<\/b><\/td><td>Intermediate risk of adverse events<\/td><td>Fewer adverse events<\/td><td>More adverse events<\/td><td>No studies reporting this outcome<\/td><\/tr><tr><td><b>Hallucinations<\/b><\/td><td><span class=\"concept\" data-cid=\"4334\">More risk of hallucinations<\/span><\/td><td>Lower risk of hallucinations<\/td><td>Lower risk of hallucinations<\/td><td>No studies reporting this outcome<\/td><\/tr><\/tbody><\/table><\/div><br \/><br \/><h5 class='notes-heading'>Specific points regarding Parkinson's medication<\/h5><br \/>NICE reminds us of the risk of acute akinesia or neuroleptic malignant syndrome if medication is not taken\/absorbed (for example due to gastroenteritis) and advise against giving patients a 'drug holiday' for the same reason.<br \/><br \/>Impulse control disorders have become a significant issue in recent years. These can occur with any dopaminergic therapy but are more common with:<br \/><ul><li><span class=\"concept\" data-cid=\"5640\">dopamine agonist therapy<\/span><\/li><li>a history of previous impulsive behaviours<\/li><li>a history of alcohol consumption and\/or smoking<\/li><\/ul><br \/>If excessive daytime sleepiness develops then patients should not drive. Medication should be adjusted to control symptoms. Modafinil can be considered if alternative strategies fail.<br \/><br \/>If orthostatic hypotension develops then a medication review looking at potential causes should be done. If symptoms persist then midodrine (acts on peripheral alpha-adrenergic receptors to increase arterial resistance) can be considered.<br \/><br \/><span class=\"concept\" data-cid=\"9533\">Consider glycopyrronium bromide to manage drooling of saliva in people with Parkinson's disease.<\/span><br \/><br \/><h5 class='notes-heading'>Further information regarding specific anti-Parkinson's medication<\/h5><br \/><br \/>Levodopa<br \/><ul><li>nearly always combined with a decarboxylase inhibitor (e.g. carbidopa or benserazide)<ul><li>this prevents the peripheral metabolism of levodopa to dopamine outside of the brain and hence can reduce side effects<\/li><\/ul><\/li><li>common adverse effects: <ul><li><span class=\"concept\" data-cid=\"6272\">dry mouth<\/span><\/li><li><span class=\"concept\" data-cid=\"6273\">anorexia<\/span><\/li><li><span class=\"concept\" data-cid=\"6274\">palpitations<\/span><\/li><li><span class=\"concept\" data-cid=\"6275\">postural hypotension<\/span><\/li><li><span class=\"concept\" data-cid=\"6276\">psychosis<\/span><\/li><\/ul><\/li><li>some adverse effects are due to the difficulty in achieving a steady dose of levodopa<ul><li><span class=\"concept\" data-cid=\"11755\">end-of-dose wearing off<\/span>: symptoms often worsen towards the end of dosage interval. This results in a decline of motor activity<\/li><li><span class=\"concept\" data-cid=\"11756\">'on-off' phenomenon<\/span>: large variations in motor performance, with normal function during the 'on' period, and weakness and restricted mobility during the 'off' period<\/li><li><span class=\"concept\" data-cid=\"6277\">dyskinesias at peak dose: dystonia, chorea and athetosis (involuntary writhing movements)<\/span><\/li><li>these effects may worsen over time with - clinicians therefore may limit doses until necessary<\/li><\/ul><\/li><li>it is important <span class=\"concept\" data-cid=\"5641\">not to acutely stop levodopa<\/span>, for example, if a patient is admitted to hospital<ul><li>if a patient with Parkinson's disease cannot take levodopa orally, they can be given a dopamine agonist patch as <span class=\"concept\" data-cid=\"5643\">rescue medication<\/span> to prevent acute dystonia<\/li><\/ul><\/li><\/ul><br \/>Dopamine receptor agonists<br \/><ul><li>e.g. <span class=\"concept\" data-cid=\"6282\">bromocriptine<\/span>, <span class=\"concept\" data-cid=\"665\">ropinirole<\/span>, <span class=\"concept\" data-cid=\"6284\">cabergoline<\/span>, <span class=\"concept\" data-cid=\"6285\">apomorphine<\/span><\/li><li>ergot-derived dopamine receptor agonists (bromocriptine, cabergoline) have been associated with <span class=\"concept\" data-cid=\"6278\">pulmonary, retroperitoneal and cardiac fibrosis<\/span>. The Committee on Safety of Medicines advice that an echocardiogram, ESR, creatinine and chest x-ray should be obtained prior to treatment and patients should be closely monitored<\/li><li>patients should be warned about the potential for dopamine receptor agonists to cause impulse control disorders and excessive daytime somnolence<\/li><li>more likely than levodopa to cause hallucinations in older patients. Nasal congestion and postural hypotension are also seen in some patients<\/li><\/ul> <br \/>MAO-B (Monoamine Oxidase-B) inhibitors<br \/><ul><li>e.g. <span class=\"concept\" data-cid=\"6286\">selegiline<\/span><\/li><li>inhibits the breakdown of dopamine secreted by the dopaminergic neurons<\/li><\/ul><br \/>Amantadine<br \/><ul><li>mechanism is not fully understood, probably increases dopamine release and inhibits its uptake at dopaminergic synapses<\/li><li>side-effects include <span class=\"concept\" data-cid=\"6302\">ataxia<\/span>, <span class=\"concept\" data-cid=\"6303\">slurred speech<\/span>, <span class=\"concept\" data-cid=\"6304\">confusion<\/span>, <span class=\"concept\" data-cid=\"6305\">dizziness<\/span> and <span class=\"concept\" data-cid=\"6306\">livedo reticularis<\/span><\/li><\/ul><br \/>COMT (Catechol-O-Methyl Transferase) inhibitors<br \/><ul><li>e.g. <span class=\"concept\" data-cid=\"6287\">entacapone<\/span>, <span class=\"concept\" data-cid=\"6291\">tolcapone<\/span><\/li><li>COMT is an enzyme involved in the breakdown of dopamine, and hence may be used as an adjunct to levodopa therapy<\/li><li>used in conjunction with levodopa in patients with established PD<\/li><\/ul><br \/>Antimuscarinics<br \/><ul><li>block cholinergic receptors<\/li><li>now used more to treat drug-induced parkinsonism rather than idiopathic Parkinson's disease<\/li><li>help tremor and rigidity<\/li><li>e.g. <span class=\"concept\" data-cid=\"6290\">procyclidine<\/span>, <span class=\"concept\" data-cid=\"6289\">benzotropine<\/span>, trihexyphenidyl (<span class=\"concept\" data-cid=\"6288\">benzhexol<\/span>)<\/li><\/ul><br \/><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/swb025b.jpg'><img class='ajaximage' src='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/swb025.jpg'\/><\/a><\/td><\/tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>Image sourced from <\/span><a href='https:\/\/en.wikipedia.org\/wiki\/Main_Page'  target='_blank' style = 'font-size:11px; color:LightGray;' >Wikipedia<\/a><\/td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/swb025b.jpg'><img src='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/css\/images\/mag_glass.png'\/><\/a><\/td><\/tr><\/table><\/CENTER><div class='imagetext'>Diagram showing the mechanism of action of Parkinson's drugs<br \/><\/div>","notes_hash":"522482862f1c510c228543b95ca1ada0","knowledge_graph_node_id_link":1019,"links":"<table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_261\" data-linkid=\"261\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_261\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">24<\/span><button type=\"button\" style=\"\" id=\"link_dislike_261\" data-linkid=\"261\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_261\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">18<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng71\/chapter\/Recommendations\">2017 Parkinson's disease guidelines<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/Z84iypHdftQ\" data-description=\"Pharmacology - DRUGS FOR PARKINSON'S DISEASE\" data-upvotes=\"27\" data-downvotes=\"0\" data-media=\"1069\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/Z84iypHdftQ\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/Z84iypHdftQ\" data-description=\"Pharmacology - DRUGS FOR PARKINSON'S DISEASE\" data-upvotes=\"27\" data-downvotes=\"0\" data-media=\"1069\">Pharmacology - DRUGS FOR PARKINSON'S DISEASE<\/a><\/td><\/tr><tr><td><span ><small>Speed Pharmacology - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1863\" data-mediaid=\"1863\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1863\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">27<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1863\" data-mediaid=\"1863\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1863\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/_pZmMU2xLM8\" data-description=\"Understanding Parkinson's Disease\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1364\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/_pZmMU2xLM8\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/_pZmMU2xLM8\" data-description=\"Understanding Parkinson's Disease\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1364\">Understanding Parkinson's Disease<\/a><\/td><\/tr><tr><td><span ><small>Rhesus Medicine - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2396\" data-mediaid=\"2396\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_2396\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0<\/span><button type=\"button\" style=\"\" id=\"media_dislike_2396\" data-mediaid=\"2396\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_2396\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/iO-M7jq-zuY\" data-description=\"Pharmacology - Parkinson's Disease\" data-upvotes=\"6\" data-downvotes=\"1\" data-media=\"276\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/iO-M7jq-zuY\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/iO-M7jq-zuY\" data-description=\"Pharmacology - Parkinson's Disease\" data-upvotes=\"6\" data-downvotes=\"1\" data-media=\"276\">Pharmacology - Parkinson's Disease<\/a><\/td><\/tr><tr><td><span ><small>Armando Hasudungan - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_471\" data-mediaid=\"471\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_471\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6<\/span><button type=\"button\" style=\"\" id=\"media_dislike_471\" data-mediaid=\"471\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_471\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/Mz_tEu835Yg\" data-description=\"Parkinson's disease pharmacology\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"312\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/Mz_tEu835Yg\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/Mz_tEu835Yg\" data-description=\"Parkinson's disease pharmacology\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"312\">Parkinson's disease pharmacology<\/a><\/td><\/tr><tr><td><span ><small>Soton Brain Hub - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_531\" data-mediaid=\"531\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_531\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5<\/span><button type=\"button\" style=\"\" id=\"media_dislike_531\" data-mediaid=\"531\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_531\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/Zg5o8Mn5g-Q\" data-description=\"The use of Levodopa\/ Carbidopa in the treatment of Parkinson's disease\" data-upvotes=\"8\" data-downvotes=\"2\" data-media=\"687\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/Zg5o8Mn5g-Q\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/Zg5o8Mn5g-Q\" data-description=\"The use of Levodopa\/ Carbidopa in the treatment of Parkinson's disease\" data-upvotes=\"8\" data-downvotes=\"2\" data-media=\"687\">The use of Levodopa\/ Carbidopa in the treatment of Parkinson's disease<\/a><\/td><\/tr><tr><td><span ><small>Medicosis Perfectionalis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1184\" data-mediaid=\"1184\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1184\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">8<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1184\" data-mediaid=\"1184\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1184\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/ARdGaE1sbBM\" data-description=\"Parkinson's disease\" data-upvotes=\"3\" data-downvotes=\"2\" data-media=\"5\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/ARdGaE1sbBM\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/ARdGaE1sbBM\" data-description=\"Parkinson's disease\" data-upvotes=\"3\" data-downvotes=\"2\" data-media=\"5\">Parkinson's disease<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_12\" data-mediaid=\"12\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_12\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3<\/span><button type=\"button\" style=\"\" id=\"media_dislike_12\" data-mediaid=\"12\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_12\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"1213":{"concept_text":"Levodopa should be offered for patients with newly diagnosed Parkinson's who have motor symptoms affecting their quality of life","concept_percentile":"95"},"4334":{"concept_text":"Parkinson's disease medications: dopamine agonists have a higher risk of hallucinations compared to the other classes of medications","concept_percentile":"88"},"6272":{"concept_text":"Levodopa may cause dry mouth","concept_percentile":"14"},"6273":{"concept_text":"Levodopa may cause anorexia","concept_percentile":"4"},"6274":{"concept_text":"Levodopa may cause palpitations","concept_percentile":"10"},"6275":{"concept_text":"Levodopa may cause postural hypotension","concept_percentile":"14"},"6276":{"concept_text":"Levodopa may cause psychosis","concept_percentile":"18"},"6277":{"concept_text":"Patients taking levodopa may experience dyskinesias at peak dose: dystonia, chorea and athetosis (involuntary writhing movements)","concept_percentile":"41"},"6278":{"concept_text":"Bromocriptine may cause pulmonary, retroperitoneal and cardiac fibrosis","concept_percentile":"7"}},"category_name":"Psychiatry \/ Neurology","subcategory_name":"Neurology","comment_count":12},"",[]]